AMA
Lamkowski A, Kałużna M, Pabin T. Valsalva retinopathy – a patient with a Leiden mutation in the coagulation factor V gene and increased blood clotting. Klinika Oczna / Acta Ophthalmologica Polonica. 2023;125(1):56-59. doi:10.5114/ko.2023.124702.
APA
Lamkowski, A., Kałużna, M., & Pabin, T. (2023). Valsalva retinopathy – a patient with a Leiden mutation in the coagulation factor V gene and increased blood clotting. Klinika Oczna / Acta Ophthalmologica Polonica, 125(1), 56-59. https://doi.org/10.5114/ko.2023.124702
Chicago
Lamkowski, Aleksander, Martyna Kałużna, and Tomasz Pabin. 2023. "Valsalva retinopathy – a patient with a Leiden mutation in the coagulation factor V gene and increased blood clotting". Klinika Oczna / Acta Ophthalmologica Polonica 125 (1): 56-59. doi:10.5114/ko.2023.124702.
Harvard
Lamkowski, A., Kałużna, M., and Pabin, T. (2023). Valsalva retinopathy – a patient with a Leiden mutation in the coagulation factor V gene and increased blood clotting. Klinika Oczna / Acta Ophthalmologica Polonica, 125(1), pp.56-59. https://doi.org/10.5114/ko.2023.124702
MLA
Lamkowski, Aleksander et al. "Valsalva retinopathy – a patient with a Leiden mutation in the coagulation factor V gene and increased blood clotting." Klinika Oczna / Acta Ophthalmologica Polonica, vol. 125, no. 1, 2023, pp. 56-59. doi:10.5114/ko.2023.124702.
Vancouver
Lamkowski A, Kałużna M, Pabin T. Valsalva retinopathy – a patient with a Leiden mutation in the coagulation factor V gene and increased blood clotting. Klinika Oczna / Acta Ophthalmologica Polonica. 2023;125(1):56-59. doi:10.5114/ko.2023.124702.
